Search research articles
Contact Us
Filters
Showing results (121-130 of 147) with videos related to
Page
of 15
Sort By:
Plos One
|
March 22, 2019
Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study
Ni Gusti Ayu Nanditha, Martin St-Jean, Hiwot Tafessu, et al.
BMC Health Services Research
|
February 13, 2025
Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site
Alannah Hannigan, Nandini Krishnan, Kirti Singh, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
Y Nasu, C H Bangma, G W Hull, et al.
BMC Infectious Diseases
|
March 1, 2017
Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012
Oghenowede Eyawo, Conrado Franco-Villalobos, Mark W Hull, et al.
Plos One
|
March 17, 2026
Beyond direct-acting antiviral therapy: Characterizing mental health conditions and depressive symptoms among patients recently treated for hepatitis C
Sarah E Kelly, Adedayo Ajidahun, Shannon Bytelaar, et al.
Gene Therapy
|
August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
Y Nasu, C H Bangma, G W Hull, et al.
AIDS (London, England)
|
April 5, 2019
Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up
Nadine Kronfli, Sahir R Bhatnagar, Mark W Hull, et al.
Plos One
|
September 7, 2019
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial
Darrell H S Tan, Maria Jose Rolon, Maria Ines Figueroa, et al.
Journal of the International AIDS Society
|
September 15, 2016
Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
Silvia A Guillemi, Sean H Ling, Julia S Dahlby, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 11, 2022
Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada
Kyle A Thompson, Gabriel Blank, Junine Toy, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 147) with videos related to
Sort By:
Page
of 15
Plos One
|
March 22, 2019
Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study
Ni Gusti Ayu Nanditha, Martin St-Jean, Hiwot Tafessu, et al.
BMC Health Services Research
|
February 13, 2025
Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site
Alannah Hannigan, Nandini Krishnan, Kirti Singh, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
Y Nasu, C H Bangma, G W Hull, et al.
BMC Infectious Diseases
|
March 1, 2017
Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012
Oghenowede Eyawo, Conrado Franco-Villalobos, Mark W Hull, et al.
Plos One
|
March 17, 2026
Beyond direct-acting antiviral therapy: Characterizing mental health conditions and depressive symptoms among patients recently treated for hepatitis C
Sarah E Kelly, Adedayo Ajidahun, Shannon Bytelaar, et al.
Gene Therapy
|
August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
Y Nasu, C H Bangma, G W Hull, et al.
AIDS (London, England)
|
April 5, 2019
Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up
Nadine Kronfli, Sahir R Bhatnagar, Mark W Hull, et al.
Plos One
|
September 7, 2019
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial
Darrell H S Tan, Maria Jose Rolon, Maria Ines Figueroa, et al.
Journal of the International AIDS Society
|
September 15, 2016
Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
Silvia A Guillemi, Sean H Ling, Julia S Dahlby, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 11, 2022
Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada
Kyle A Thompson, Gabriel Blank, Junine Toy, et al.
Page
of 15